Amniotic membrane extract eye drops (AMEED) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 53 | Sjogren syndrome | 1 |
53. Sjogren syndrome
Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05598242 (ClinicalTrials.gov) | February 1, 2019 | 20/10/2022 | Amniotic Membrane Treatment for Hyposecretory Dry Eye | Amniotic Membrane Treatment for Hyposecretory Dry Eye | Dry Eye Syndromes;Sjogren Syndrome With Keratoconjunctivitis | Biological: Amniotic membrane extract eye drops (AMEED) | Hospital Nacional Profesor Alejandro Posadas | NULL | Completed | 21 Years | N/A | Female | 37 | Phase 3 | Argentina |